Metabolic Testing Market

Metabolic
Testing
Market
Opportunity Analysis, 2018-2026
Outlook,
and
Metabolic testing involves assessment of health and wellbeing of an individual. Metabolic testing
equipment are used to screen organ functions and disease conditions such as liver diseases,
diabetes, kidney diseases, and cardiovascular diseases. Metabolism is a chemical reaction
occurring in the body to maintain the standard state of the organism or body. Metabolic
syndrome is a group of metabolic disorders such as high blood pressure with high fasting
glucose levels and abnormal obesity. Metabolism pattern and metabolic capacity is determined
with the help of metabolic testing for management of such conditions. In case of sports
professionals, metabolic testing is done in order to test body’s ability of oxygen consumption.
Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/1652
Launch and Approval of Advanced Metabolic Testing Devices
Key players in the market are focused on introducing advanced devices such as body
composition analyzers, metabolic carts, and electrocardiogram (ECGs/EKGs). Key players such as
InBody Co. Ltd., Korr Medical Technologies, Cosmed srl, Vyaire Medical, and OSI Systems, Inc.
offer products in the market in different segments. For instance, in 2017, Cosmed received
innovative technology designation from Vizient, Inc. for its K5 Wearable Metabolic System. The
system comes with micro-dynamic mixing chamber or breath-by-breath gas exchange techniques,
wireless connectivity, a standard USB port, and medical grade AC/DC power plug.
Moreover, portable VO2 max analysis devices have been introduced in the market by players
such as VO2 Master. VO2 Master product VO2 Master Pro is a wearable VO2 analyzer with
Bluetooth connectivity. AEI Technologies offers PC-based stress ECG system, which can turn any
PC into an all-in-one cardiology system.
Furthermore, in October 2017, InBody Co., Ltd. launched InBody BAND 2 — a fusion of body
composition analyzers and fitness trackers. InBody BAND 2 is capable of measuring percent
body fat, fat mass, muscle mass, sleep monitoring, heart rate monitoring, and fitness tracking.
Therefore, launch of advanced metabolic testing devices is expected to significantly boost
metabolic testing market growth over the forecast period.
Report includes chapters which deeply display the following deliverable about industry :
• Metabolic Testing Market Research Objective and Assumption
• Metabolic Testing Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Metabolic Testing Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Metabolic Testing Market, By Regions
• Metabolic Testing Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Metabolic Testing Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Metabolic Testing Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Metabolic Testing Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Market Dynamics
Increasing approval and launch of new products, high prevalence of lifestyle diseases, and
better reimbursement policies is expected to be major factors drastically driving metabolic
testing market growth. For instance, manufacturers have introduced products such as Quark
CPET (Cosmed srl) with multiple configurations such as ECG testing and nutritional assessment
and products such as ReeVue (Korr Medical Technologies Inc.) with mixing chamber technology,
self-calibration, and reimbursement facility.
Prevalence of lifestyle diseases is high in key region. Lifestyle diseases can lead to metabolic
diseases which in turn is expected to rise demands for metabolic testing devices and drive
metabolic testing market growth. For instance, according to the Centers for Disease Control and
Prevention (CDC), over one third of the adults in the U.S. had obesity in 2014.
However, high cost of metabolic testing devices, preference to these devices under limited
circumstances (sports performance testing and others), low penetration in emerging economies in
regions such as Latin America, Asia Pacific, and Middle East are factors that are expected to
restrain growth of the market.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/metabolic-testing-market-1652
Key players operating in the metabolic testing market include, Cosmed srl, Vyaire Medical, Inc.,
Geratherm Medical AG, MGC Diagnostics Corporation, Cortex Biophysik GmbH, General Electric
Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc.,
and Korr Medical Technologies, Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Metabolic testing involves assessment of health and wellbeing of an individual. Metabolic testing equipment are used to screen organ functions and disease conditions such as liver diseases, diabetes, kidney diseases, and cardiovascular diseases.